Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6601–6650 of 18417
the Board approved the promotion of Annette L. Burns to Chief Financial Officer of the Company, effective May 21, 2024.
The appointment follows the decision of the Board on January 19, 2024 to place Vikram Luthar, the Company’s Chief Financial Officer and Senior Vice President, on administrative leave, effective immediately.
On January 21, 2024, Archer-Daniels-Midland Company (the “Company”) announced that the Board of Directors of the Company (the “Board”) has appointed Ismael Roig to serve as the Company’s Interim Chief Financial Officer.
On January 21, 2024 (the “ Effective Date ”), Edmond Thomas retired from his position as President and Chief Executive Officer of Tilly’s, Inc. (the “ Company ”) and as a director of the board of directors (the “ Board ”) of the Company.
On the Effective Date, the Board appointed Hezy Shaked, the Company’s co-founder, Chief Strategy Officer and Executive Chairman of the Board as the Company’s interim President and Chief Executive Officer, to serve in such capacities until his successor is duly elected and qualified or until his earlier death, resignation or removal.
On January 20, 2024, the board of directors (the “Board”) of Alaunos Therapeutics, Inc. (the “Company”) appointed Dale Curtis Hogue, Jr. as Interim Chief Executive Officer of the Company, effective January 20, 2024.
On January 16, 2024, in connection with the Workforce Reduction, the Company terminated Mr. W. Anderson’s employment with the Company, effective as of January 16, 2024
On January 16, 2024, the Board of Directors (the “Board”) of Energy Recovery, Inc. (the “Company”) appointed Mr. David Moon, age 61, as President and Chief Executive Officer effective immediately.
Concurrent with Ms. Sullivan’s promotion, Ann Joyce, the Company’s Interim Chief Executive Officer, will serve as an executive consultant for the Company through February 29, 2024, at which time she will no longer be employed by the Company.
the Company announced that it had promoted Amy A. Sullivan to the position of Chief Executive Officer to be effective February 4, 2024.
On January 18, 2024, the Board of the Company elected Mark E. Zalatoris to serve as the Company’s President and Chief Executive Officer effective February 1, 2024 and elected Mr. Zalatoris to fill the vacancy resulting from Mr. Sabshon’s resignation as a director also effective February 1, 2024.
On January 13, 2024, Mitchell A. Sabshon, the President and Chief Executive Officer of the Company notified the Company that, because of his decision to retire from his position with Inland Investments, an affiliate of the Company’s Business Manager, he was also resigning his position as a director of the Company and as the Company’s President and Chief Executive Officer, effective at the close of business on January 31, 2024.
appointed Benjamin G. Wolff as President and Chief Executive Officer of the Company, effective February 23, 2024
the Company has appointed Ewout L. Steenbergen as its Executive Vice President and Chief Financial Officer effective as of March 15, 2024.
Upon Mr. Steenbergen's commencement of employment, David I. Goulden will no longer serve as the Company's Chief Financial Officer.
Following the effectiveness of Dr. Diem’s resignation and until a new Chief Financial Officer is appointed, Douglas Carr, the Company’s Senior Vice President, Finance and Operations, will serve as interim Principal Financial Officer.
On January 15, 2024, Michael C. Diem, M.D. notified Century Therapeutics, Inc. (the “Company”) of his decision to resign as Chief Financial Officer of the Company, effective as of February 2, 2024.
On January 15, 2024, the Company entered into an employment agreement with Dr. Ying (the “Employment Agreement”) to serve as the Company’s Chief Executive Officer.
On January 15, 2024, David Hart was appointed Chief Executive Officer of the Company.
On January 15, 2024, Nicholas Vita retired from his position as Chief Executive Officer of The Cannabist Company Holdings Inc.
On January 18, 2024, the Board of Directors (“Board”) of the Company appointed Christopher R. Concannon, Chief Executive Officer of the Company, as interim Chief Financial Officer, effective February 1, 2024.
On November 6, 2023, MarketAxess Holdings Inc. (the “Company”) was informed by Christopher N. Gerosa, the Company’s Chief Financial Officer, that he will resign from such position effective January 31, 2024, to accept a position with another company.
and the appointment of Roger Wurtele as the Chief Financial Officer of the Company.
On January 19, 2024, the Board announced that it has appointed Gregory McCabe, the current Chairman of the Board, as Chief Executive Officer of the Company, effective as of January 15, 2024.
In addition, Luke Hawkins provided to the Company a notice of his resignation as Chief Financial Officer of the Company and all positions held at each of its subsidiaries, each effective as of January 15, 2024.
On January 15, 2024, Clifton DuBose, Jr. provided to Next Bridge Hydrocarbons, Inc. (the “Company”) a notice of his resignation from the Board of Directors (the “Board”) and as Chief Executive Officer and President of the Company and all positions held at each of its subsidiaries.
On January 11, 2024, Steven Arenal was elected as Director of the Company and appointed Chief Executive Officer, President, and Secretary of the Company.
On January 15, 2024, Christopher K. DeSalvo resigned as Chief Financial Officer and Operations Vice President of Vislink Technologies, Inc. (the “Company”).
Effective January 19, 2024, Michael C. Bond will immediately assume the duties as Chief Financial Officer of the Company.
Effective January 17, 2024, Norman Roth the Registrant’s Controller and Principal Accounting Officer has been appointed Interim Chief Financial Officer until such time as a new Chief Financial Officer is appointed.
Effective as of January 17, 2024, Larry Steenvoorden the Chief Financial Officer and the Registrant agreed to a mutual separation.
the Board appointed Neal Walker as the Company’s Interim Chief Executive Officer and President, effective January 17, 2024.
On January 15, 2024, the Company and Douglas Manion mutually agreed that Dr. Manion will step down as the Company’s Chief Executive Officer and President and resign from the Board of Directors (the “ Board ”), effective January 16, 2024.
On January 15, 2024, the Company engaged Chris Knauf to serve as Chief Financial Officer and Controller of the Company commencing on the Effective Date.
notified Martin Scott, Chief Financial Officer of the Company, that the Company would retain a full time on site Chief Financial Officer effective following the filing of the Company’s Form 10-Q Quarterly Report for the period ended December 31, 2023 (the “Effective Date”) and Mr. Scott would no longer serve as an employee or executive officer of the Company following the Effective Date.
Concurrently with Mr. Ottomanelli’s resignation, Dana Perez was appointed as the Chief Financial Officer of the Company effective as of January 15, 2024.
Effective as of January 15, 2024, Vincent Ottomanelli resigned from his position as Chief Financial Officer of MGO Global Inc., a Delaware corporation (the “ Company ”).
On January 14, 2024, Jordan Davis resigned (i) as Chief Executive Officer of Volcon, Inc. (the “Company”) effective February 2, 2024, and (ii) as a member of the Company’s Board of Directors (the “Board”) effective February 2, 2024.
On January 16, 2024, the Board appointed Greg Endo, the Company’s current Chief Financial Officer as Interim Chief Executive Officer and principal executive officer of the Company effective February 2, 2024.
Each of the Company’s directors, Manuel D. Medina, Greg Waters, Nelson Fonseca, Fahim Ahmed, Benjamin Phillips, John W. Diercksen, Frederick Arnold, Roger Meltzer and Scott Vogel, and the Company’s remaining officers, including Nelson Fonseca, President & Chief Executive Officer and Carlos Sagasta, Chief Financial Officer ceased being directors and officers of the Company on the Effective Date.
Each of the Company’s directors, Manuel D. Medina, Greg Waters, Nelson Fonseca, Fahim Ahmed, Benjamin Phillips, John W. Diercksen, Frederick Arnold, Roger Meltzer and Scott Vogel, and the Company’s remaining officers, including Nelson Fonseca, President & Chief Executive Officer and Carlos Sagasta, Chief Financial Officer ceased being directors and officers of the Company on the Effective Date.
On January 16, 2024, Andrew Bronstein, Chief Financial Officer of Cambium Networks Corporation (the “Company”) notified the Company that he will resign as the Company’s Chief Financial Officer, effective February 2, 2024, in order to pursue other opportunities.
On January 18, 2024, the Board of Directors of the Company appointed John Becerril, age 57, as interim Acting Chief Financial Officer and principal financial officer for the period between Mr. Bronstein’s resignation effective February 2, 2024 and the commencement of employment of a new Chief Financial Officer.
Olivier Leonetti will succeed Mr. Okray as Executive Vice President and Chief Financial Officer on February 5, 2024.
On January 11, 2024 , Eaton Corporation (the “Company”) and Thomas B. Okray, Executive Vice President and Chief Financial Officer mutually agreed that effective February 2, 2024, Mr. Okray’s employment with the Company will end.
Mr. Stewart succeeds Richard J. Kramer
On January 18, 2024, The Goodyear Tire & Rubber Company (the “Company”) announced that Mark Stewart will become Chief Executive Officer and President and a member of the Board of Directors of the Company (the “Board”), effective January 29, 2024.
On January 11, 2024, the Ally Financial Inc. Board of Directors appointed Douglas R. Timmerman as Interim Chief Executive Officer ( CEO ) effective as of February 1, 2024.
the Board of Directors of the Company (the “Board”) appointed Kirk Tanner as President and Chief Executive Officer of the Company, effective February 5, 2024
Todd A. Penegor will cease to be the President and Chief Executive Officer of the Company, and will resign from the Board and all Board committees on which he served, as of the Effective Date.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.